MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    The study of the role of genetic risk factors in levodopa-induced dyskinesia development in Russian patients with Parkinson’s disease: a pilot study

    G. Akhmadeeva, I. Khidiyatova, I. Gilyazova, A. Baitimerov, G. Tayupova, R. Magzhanov (Ufa, Russian Federation)

    Objective: The aim of our study is to search for genetic risk factors for the development of motor side effects of dopaminergic therapy, such as…
  • MDS Virtual Congress 2020

    Virtual Assessment of LRRK2 Carriers to Optimize Research in Parkinson Disease (VALOR-PD): A Comparison to Traditional Cohorts

    S. Jensen-Roberts, T. Myers, K. Amodeo, S. Sharma, R. Alcalay, E. Dorsey, R. Holloway, R. Schneider (Rochester, NY, USA)

    Objective: To compare a national virtual cohort of LRRK2 G2019S carriers, identified via a personal genetics company, to existing traditional cohorts. Background: Advancements in personal…
  • MDS Virtual Congress 2020

    Biomarker Discovery in Parkinson’s disease using Machine Learning on Public Multi-omic Datasets: A Pilot Study

    M. Makarious, H. Iwaki, C. Blauwendraat, H. Leonard, S. Hashemi, J. Kim, K. Van Keuren-Jensen, D. Craig, E. Appelmans, L. Smolensky, M. Bookman, A. Singleton, F. Faghri, M. Nalls (Bethesda, MD, USA)

    Objective: In this study, we use machine learning (ML) as a framework for biomarker studies to assess if multiple modalities in the same model perform…
  • MDS Virtual Congress 2020

    The ROPAD (Rostock International Parkinson’s Disease Study) study: Towards defining the genetic epidemiology of the disease

    V. Skrahina, H. Gaber, T. Förster, T. Usnich, N. Schell, P. Bauer, X. Bogdanovic, E. Vollstedt, N. Brüggemann, I. Csoti, M. Kasten, N. Koleva-Alazeh, C. Beetz, C. Klein, A. Rolfs (Rostock, Germany)

    Objective: ROPAD is an international, multicenter, epidemiological study that aims at a better understanding of the contribution of genetics to Parkinson’s disease (PD) based on…
  • MDS Virtual Congress 2020

    Type-3 Metabotropic Glutamate Receptors and Parkinson’s Disease: Preclinical Studies and Human Genetics

    M. Alborghetti, L. Di Menna, A. Traficante, V. Bruno, J. Monn, F. Nicoletti, F.E Pontieri, E. Bianchini, G. Spalletta, M. Borro, M. Simmaco, G. Battaglia (Rome, Italy)

    Objective: In a MPTP mice model of toxicological parkinsonism we examine whether the presence or absence of mGlu3 receptors is neuroprotective. We also  evaluted association…
  • MDS Virtual Congress 2020

    Effects of exosomes devised from dopaminergic neurons overexpressing α-synuclein on autophagy and inflammation in microglia

    Y. Liang, L. Bu, E. Tao (Guangzhou,Guangdong, China)

    Objective: The aim of this study was to investigate whether the exosomes secreted by dopaminergic neurons over-expressing α-synuclein could regulate the inflammation of microglia via…
  • MDS Virtual Congress 2020

    The Influence of 3-Phenoxybenzoic Acid in Dopaminergic Degeneration

    F. Wan (Wuhan, China)

    Objective: 3-phenoxybenzoic acid (3-PBA) is a metabolite of Fenpropathrin (FEN). The emphasis of this paper is on the relationship between 3-PBA and Dopaminergic Degeneration. Background:…
  • MDS Virtual Congress 2020

    Quantitative susceptibility mapping images for the parcellation of the Subthalamic Nucleus: a possible role for targeting Deep Brain Stimulation

    E. Del Prete, P. Cecchi, D. Frosini, M. Costagli, S. Mazzucchi, G. Donatelli, G. Migaleddu, U. Bonuccelli, M. Cosottini, R. Ceravolo (Pisa, Italy)

    Objective: To investigate the iron distribution in STN in PD patients using QSM images. Background: Subthalamic Deep Brain Stimulation (DBS) is considered an effective treatment…
  • MDS Virtual Congress 2020

    Right hemispheric β-amyloid deposition associates with freezing of gait in Parkinson’s disease

    P. Kanel, M. Müller, K. Frey, N. Bohnen (Ann Arbor, MI, USA)

    Objective: To investigate regional cerebral deposition of β-amyloid in patients with Parkinson's disease (PD) who have freezing of gait (FoG). Background: FoG is one of…
  • MDS Virtual Congress 2020

    Retinal thinning and disease worsening in Lewy body diseases

    A. Murueta-Goyena, R. Del Pino, M. Galdós, B. Arana, M. Acera, MM. Carmona-Abellán, P. Reyero, B. Tijero, O. Lucas-Jiménez, N. Ibarretxe-Bilbao, N. Ojeda, J. Peña, J.C Gómez-Esteban, I. Gabilondo (Barakaldo, Spain)

    Objective: To assess longitudinal changes of retinal thickness measurements and their role as biomarkers of disease progression in patients with Lewy body diseases (LBDs). Background:…
  • « Previous Page
  • 1
  • …
  • 135
  • 136
  • 137
  • 138
  • 139
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Movement disorders in chronic obstructive pulmonary disease (COPD); the effect of pulmonary disease to brain
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley